FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4293404335> ?p ?o ?g. }

• W4293404335 abstract "Background To evaluate the effect of oral anticoagulants (OACs) therapy, including vitamin K antagonist (VKA) and direct oral anticoagulants (DOAC) in patients with pulmonary diseases. Methods Literature from PubMed, MEDLINE, and Cochrane Library were screened until June 2022. Studies assessing OACs for pulmonary hypertension (PH), pulmonary embolism (PE), pulmonary fibrosis (PF), or chronic obstructive pulmonary disease (COPD) were evaluated for inclusion. Results Our study indicated that in patients with PH, PE, and COPD, OACs could significantly reduce the mortality risk, and the effects of VKA and DOACs without statistical difference in reducing the risk of recurrent embolism events. In patients with sclerosis-associated pulmonary arterial hypertension (SSc-PAH) or idiopathic pulmonary fibrosis (IPF), vitamin K antagonist (warfarin) significantly increased the mortality risk, while DOACs were not. As for the safety outcome of OACs, existing studies indicate that compared with patients treated with warfarin, the users of DOAC have a lower risk of major bleeding, while there is no statistical significance between them in non-major bleeding events. In current guidelines, the anticoagulation regimen for patients with pulmonary disease has not been defined. The results of our study confirm that DOACs (apixaban, rivaroxaban, dabigatran, and edoxaban) are superior to VKAs in the efficacy and safety outcomes of patients with pulmonary disease. Conclusions Oral anticoagulant therapy brings benefits to patients with PH, PE, or COPD, while the anticoagulation regimen for patients with SSc-PAH or IPF requires serious consideration. Compared with VKA, DOAC is a non-inferior option for anticoagulation in pulmonary disease treatment. Further studies are still needed to provide more reliable evidence about the safety outcome of pulmonary disease anticoagulation." @default.
• W4293404335 created "2022-08-28" @default.
• W4293404335 creator A5021687717 @default.
• W4293404335 creator A5026874493 @default.
• W4293404335 creator A5046914548 @default.
• W4293404335 creator A5056748312 @default.
• W4293404335 date "2022-08-10" @default.
• W4293404335 modified "2023-09-30" @default.
• W4293404335 title "Effects of oral anticoagulant therapy in patients with pulmonary diseases" @default.
• W4293404335 cites W1592091620 @default.
• W4293404335 cites W1866413456 @default.
• W4293404335 cites W1889364224 @default.
• W4293404335 cites W1941375225 @default.
• W4293404335 cites W1974227996 @default.
• W4293404335 cites W1995399348 @default.
• W4293404335 cites W1998354077 @default.
• W4293404335 cites W2020363094 @default.
• W4293404335 cites W2035384054 @default.
• W4293404335 cites W2051879911 @default.
• W4293404335 cites W2055609841 @default.
• W4293404335 cites W2060665196 @default.
• W4293404335 cites W2072760771 @default.
• W4293404335 cites W2075196907 @default.
• W4293404335 cites W2076922065 @default.
• W4293404335 cites W2106564183 @default.
• W4293404335 cites W2118232066 @default.
• W4293404335 cites W2120203545 @default.
• W4293404335 cites W2120642548 @default.
• W4293404335 cites W2129520400 @default.
• W4293404335 cites W2130199362 @default.
• W4293404335 cites W2131237771 @default.
• W4293404335 cites W2138213458 @default.
• W4293404335 cites W2142503372 @default.
• W4293404335 cites W2144471064 @default.
• W4293404335 cites W2147724938 @default.
• W4293404335 cites W2148744507 @default.
• W4293404335 cites W2158675907 @default.
• W4293404335 cites W2160625453 @default.
• W4293404335 cites W2166402206 @default.
• W4293404335 cites W2184677300 @default.
• W4293404335 cites W2511180897 @default.
• W4293404335 cites W2517192979 @default.
• W4293404335 cites W2583679349 @default.
• W4293404335 cites W2614800967 @default.
• W4293404335 cites W2619684371 @default.
• W4293404335 cites W2623482004 @default.
• W4293404335 cites W2807020572 @default.
• W4293404335 cites W2810746417 @default.
• W4293404335 cites W2895442075 @default.
• W4293404335 cites W2897313468 @default.
• W4293404335 cites W2920668611 @default.
• W4293404335 cites W2944047291 @default.
• W4293404335 cites W2945592394 @default.
• W4293404335 cites W2969628772 @default.
• W4293404335 cites W2981691390 @default.
• W4293404335 cites W3012348059 @default.
• W4293404335 cites W3093176672 @default.
• W4293404335 cites W3100777404 @default.
• W4293404335 cites W3119892951 @default.
• W4293404335 cites W3138238585 @default.
• W4293404335 cites W3215905814 @default.
• W4293404335 cites W4226116895 @default.
• W4293404335 doi "https://doi.org/10.3389/fcvm.2022.987652" @default.
• W4293404335 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36035947" @default.
• W4293404335 hasPublicationYear "2022" @default.
• W4293404335 type Work @default.
• W4293404335 citedByCount "1" @default.
• W4293404335 countsByYear W42934043352023 @default.
• W4293404335 crossrefType "journal-article" @default.
• W4293404335 hasAuthorship W4293404335A5021687717 @default.
• W4293404335 hasAuthorship W4293404335A5026874493 @default.
• W4293404335 hasAuthorship W4293404335A5046914548 @default.
• W4293404335 hasAuthorship W4293404335A5056748312 @default.
• W4293404335 hasBestOaLocation W42934043351 @default.
• W4293404335 hasConcept C126322002 @default.
• W4293404335 hasConcept C177713679 @default.
• W4293404335 hasConcept C2776265017 @default.
• W4293404335 hasConcept C2776301958 @default.
• W4293404335 hasConcept C2776704044 @default.
• W4293404335 hasConcept C2776780178 @default.
• W4293404335 hasConcept C2778661090 @default.
• W4293404335 hasConcept C2778810321 @default.
• W4293404335 hasConcept C2779161974 @default.
• W4293404335 hasConcept C2780290652 @default.
• W4293404335 hasConcept C2780638905 @default.
• W4293404335 hasConcept C2780930700 @default.
• W4293404335 hasConcept C71924100 @default.
• W4293404335 hasConceptScore W4293404335C126322002 @default.
• W4293404335 hasConceptScore W4293404335C177713679 @default.
• W4293404335 hasConceptScore W4293404335C2776265017 @default.
• W4293404335 hasConceptScore W4293404335C2776301958 @default.
• W4293404335 hasConceptScore W4293404335C2776704044 @default.
• W4293404335 hasConceptScore W4293404335C2776780178 @default.
• W4293404335 hasConceptScore W4293404335C2778661090 @default.
• W4293404335 hasConceptScore W4293404335C2778810321 @default.
• W4293404335 hasConceptScore W4293404335C2779161974 @default.
• W4293404335 hasConceptScore W4293404335C2780290652 @default.
• W4293404335 hasConceptScore W4293404335C2780638905 @default.
• W4293404335 hasConceptScore W4293404335C2780930700 @default.
• W4293404335 hasConceptScore W4293404335C71924100 @default.

• next